Loading...
The 2024 American Society of Clinical Oncology (ASCO) annual meeting, held May 30 to June 3 in Chicago, showcased important and potentially practice-changing studies across a broad spectrum of gastrointestinal (GI) malignancies. The role of radiation therapy in upper GI cancers, the role of surgery in metastatic colorectal cancer, and the application of immune checkpoint inhibitors in GI cancers were key themes in the presentations. Here, Associate Editor Dr. David Ilson reviews key trials.
The plenary session included the German ESOPEC study comparing two preoperative strategies in locally advanced adenocarcinoma of the esophagus and gastroesophageal junction (GEJ; abstract LBA1). Res…